image
Healthcare - Medical - Instruments & Supplies - NYSE - US
$ 134.65
-3.94 %
$ 8.88 B
Market Cap
24.39
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ATR stock under the worst case scenario is HIDDEN Compared to the current market price of 135 USD, AptarGroup, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ATR stock under the base case scenario is HIDDEN Compared to the current market price of 135 USD, AptarGroup, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one ATR stock under the best case scenario is HIDDEN Compared to the current market price of 135 USD, AptarGroup, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ATR

image
$180.0$180.0$175.0$175.0$170.0$170.0$165.0$165.0$160.0$160.0$155.0$155.0$150.0$150.0$145.0$145.0$140.0$140.0$135.0$135.0$130.0$130.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
3.58 B REVENUE
2.74%
496 M OPERATING INCOME
22.89%
374 M NET INCOME
31.67%
643 M OPERATING CASH FLOW
11.85%
-397 M INVESTING CASH FLOW
-22.27%
-225 M FINANCING CASH FLOW
-31.35%
848 M REVENUE
-6.73%
120 M OPERATING INCOME
-13.15%
101 M NET INCOME
0.94%
178 M OPERATING CASH FLOW
-22.26%
-171 M INVESTING CASH FLOW
-112.06%
-87.7 M FINANCING CASH FLOW
-80.29%
Balance Sheet AptarGroup, Inc.
image
Current Assets 1.48 B
Cash & Short-Term Investments 226 M
Receivables 658 M
Other Current Assets 594 M
Non-Current Assets 2.95 B
Long-Term Investments 146 M
PP&E 1.51 B
Other Non-Current Assets 1.3 B
5.10 %14.85 %13.40 %3.30 %34.10 %29.25 %Total Assets$4.4b
Current Liabilities 1.07 B
Accounts Payable 296 M
Short-Term Debt 338 M
Other Current Liabilities 434 M
Non-Current Liabilities 878 M
Long-Term Debt 738 M
Other Non-Current Liabilities 140 M
15.21 %17.38 %22.30 %37.91 %7.21 %Total Liabilities$1.9b
EFFICIENCY
Earnings Waterfall AptarGroup, Inc.
image
Revenue 3.58 B
Cost Of Revenue 0
Gross Profit 3.58 B
Operating Expenses 3.09 B
Operating Income 496 M
Other Expenses 122 M
Net Income 374 M
4b4b4b4b3b3b3b3b2b2b2b2b1b1b500m500m004b04b(3b)496m(122m)374mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
100.00% GROSS MARGIN
100.00%
13.86% OPERATING MARGIN
13.86%
10.45% NET MARGIN
10.45%
783.54% ROE
783.54%
8.45% ROA
8.45%
10.68% ROIC
10.68%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis AptarGroup, Inc.
image
400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 374 M
Depreciation & Amortization 220 M
Capital Expenditures -276 M
Stock-Based Compensation 47.6 M
Change in Working Capital 0
Others 23.3 M
Free Cash Flow 367 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets AptarGroup, Inc.
image
Wall Street analysts predict an average 1-year price target for ATR of $154 , with forecasts ranging from a low of $45 to a high of $215 .
ATR Lowest Price Target Wall Street Target
45 USD -66.58%
ATR Average Price Target Wall Street Target
154 USD 14.05%
ATR Highest Price Target Wall Street Target
215 USD 59.67%
Price
Max Price Target
Min Price Target
Average Price Target
220220200200180180160160140140120120100100808060604040May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.29% DIVIDEND YIELD
0.45 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.801.801.601.601.401.401.201.201.001.000.800.800.600.600.400.400.200.200.000.000.280.30.320.320.340.360.360.380.380.410.450.280.30.320.320.360.360.380.380.380.410.280.30.320.340.360.360.380.380.410.450.31.140.321.220.321.280.341.320.361.420.361.440.381.500.381.520.411.580.451.720.452015201520162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership AptarGroup, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
6.29 M USD 4
6-9 MONTHS
15.3 M USD 8
9-12 MONTHS
1.27 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment. businesswire.com - 3 weeks ago
Zacks Industry Outlook Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products Packaging Corporation of America, Amcor, AptarGroup and Sonoco Products have been highlighted in this Industry Outlook article. zacks.com - 2 months ago
AptarGroup Earnings Surpass Estimates in Q4, Increase 27% Y/Y ATR's Q4 top line gains from improved performances of the Pharma and Closures segments. zacks.com - 2 months ago
International Markets and AptarGroup (ATR): A Deep Dive for Investors Explore AptarGroup's (ATR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. zacks.com - 2 months ago
AptarGroup, Inc. (ATR) Q4 2024 Earnings Call Transcript AptarGroup, Inc. (NYSE:ATR ) Q4 2024 Earnings Conference Call February 7, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President, Investor Relations & Communications Stephan Tanda - President & Chief Executive Officer Vanessa Kanu - Executive Vice President & Chief Financial Officer Conference Call Participants George Staphos - Bank of America Ghansham Panjabi - Baird Matt Roberts - Raymond James Daniel Rizzo - Jefferies Matt Larew - William Blair Gabe Hajde - Wells Fargo Operator Ladies and gentlemen, thank you for standing by. Welcome to Aptar's 2024 Fourth Quarter and Annual Results Conference Call. seekingalpha.com - 2 months ago
AptarGroup (ATR) Tops Q4 Earnings Estimates AptarGroup (ATR) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.21 per share a year ago. zacks.com - 2 months ago
Aptar Reports Fourth Quarter and Annual 2024 Results CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2024 Results. businesswire.com - 2 months ago
AptarGroup (ATR) Reports Next Week: Wall Street Expects Earnings Growth AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 months ago
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details. businesswire.com - 2 months ago
Top 3 Materials Stocks That Are Set To Fly This Month The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies. benzinga.com - 3 months ago
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report? AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 3 months ago
Aptar Announces 2025 Quarterly Conference Call Dates CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2025 Quarterly Conference Call Dates. businesswire.com - 3 months ago
8. Profile Summary

AptarGroup, Inc. ATR

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 8.88 B
Dividend Yield 0.29%
Description AptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Contact 265 Exchange Drive, Crystal Lake, IL, 60014 https://www.aptar.com
IPO Date April 23, 1993
Employees 13500
Officers Mr. Marc Prieur President of Aptar Beauty Ms. Xiangwei Gong Executive Vice President of President & Strategic Group Dev. and President of Aptar Asia Mr. Stephan B. Tanda President, Chief Executive Officer & Executive Director Mr. Gael Touya President of Aptar Pharma